{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:01:26Z","timestamp":1789999286838,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Natural killer (NK) cells are critical for both innate and adaptive immunity, and their effective regulation holds significant promise for tumor immunotherapy. The terminal maturation of NK cells is closely associated with enhanced effector functions, but the role of epigenetic mechanisms in this process remains incompletely understood. Here, we identify the histone methyltransferase EHMT2 as an epigenetic regulator that restrains NK cell maturation and function. EHMT2 expression is markedly downregulated upon cytokine activation in human NK cells and inversely correlated with effector gene expression across tissues and cancer types. NK cell-specific deletion of Ehmt2 in mice promotes terminal NK cell maturation, augmenting IFN-\u03b3 production and cytotoxicity both in vitro and in vivo. Integrated RNA-seq and H3K9me2 CUT&amp;Tag profiling reveal that Ehmt2 loss reduces the repressive histone mark H3K9me2 and derepresses transcriptional programs associated with NK cell differentiation and cytotoxicity. Pharmacological inhibition of EHMT2 recapitulated these effects in both human umbilical cord blood (hUCB)-hematopoietic stem cell (HSC)-derived NK cells and peripheral blood NK cells, promoting terminal maturation and tumor cell killing. These findings define EHMT2-dependent H3K9me2 deposition as a key epigenetic barrier to NK cell effector programming and suggest that targeting EHMT2 may potentiate NK cell-based immunotherapies.<\/jats:p>","DOI":"10.1038\/s41419-026-09124-y","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:03:47Z","timestamp":1784873027000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting EHMT2 enhances NK cell maturation and antitumor activity"],"prefix":"10.1038","volume":"17","author":[{"given":"Minghang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9661-698X","authenticated-orcid":false,"given":"Xinhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6707-1187","authenticated-orcid":false,"given":"Ning","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8218-6395","authenticated-orcid":false,"given":"Zilong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6753-3053","authenticated-orcid":false,"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0480-9491","authenticated-orcid":false,"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"9124_CR1","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41590-020-0728-z","volume":"21","author":"T Bald","year":"2020","unstructured":"Bald T, Krummel MF, Smyth MJ, Barry KC. The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies. Nat Immunol. 2020;21:835\u201347.","journal-title":"Nat Immunol"},{"key":"9124_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-020-01014-w","volume":"14","author":"S Liu","year":"2021","unstructured":"Liu S, Galat V, Galat Y, Lee YKA, Wainwright D, Wu J. NK cell-based cancer immunotherapy: from basic biology to clinical development. J Hematol Oncol. 2021;14:7.","journal-title":"J Hematol Oncol"},{"key":"9124_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13791","volume":"58","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Chen Y, Ba Y, Xu H, Zuo A, Liu S, et al. Revolutionising cancer immunotherapy: advancements and prospects in non-viral CAR-NK cell engineering. Cell Prolif. 2025;58:e13791.","journal-title":"Cell Prolif"},{"key":"9124_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.it.2013.07.005","volume":"34","author":"J Yu","year":"2013","unstructured":"Yu J, Freud AG, Caligiuri MA. Location and cellular stages of natural killer cell development. Trends Immunol. 2013;34:573\u201382.","journal-title":"Trends Immunol"},{"key":"9124_CR5","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1182\/blood-2010-04-281675","volume":"116","author":"NK Bj\u00f6rkstr\u00f6m","year":"2010","unstructured":"Bj\u00f6rkstr\u00f6m NK, Riese P, Heuts F, Andersson S, Fauriat C, Ivarsson MA, et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood. 2010;116:3853\u201364.","journal-title":"Blood"},{"key":"9124_CR6","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1182\/blood-2010-04-282301","volume":"116","author":"S Lopez-Verg\u00e8s","year":"2010","unstructured":"Lopez-Verg\u00e8s S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood. 2010;116:3865\u201374.","journal-title":"Blood"},{"key":"9124_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3389\/fimmu.2013.00422","volume":"4","author":"CM Nielsen","year":"2013","unstructured":"Nielsen CM, White MJ, Goodier MR, Riley EM. Functional significance of CD57 expression on human NK cells and relevance to disease. Front Immunol. 2013;4:422.","journal-title":"Front Immunol"},{"key":"9124_CR8","doi-asserted-by":"crossref","unstructured":"Tang F, Li J, Qi L, Liu D, Bo Y, Qin S, et al. A pan-cancer single-cell panorama of human natural killer cells. Cell. 2023;186:4235\u201351.e20.","DOI":"10.1016\/j.cell.2023.07.034"},{"key":"9124_CR9","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.4049\/jimmunol.1701700","volume":"200","author":"DJ Verbaro","year":"2018","unstructured":"Verbaro DJ, Sakurai N, Kim B, Shinkai Y, Egawa T. Cutting edge: the histone methyltransferase G9a is required for silencing of helper T lineage-associated genes in proliferating CD8 T cells. J Immunol. 2018;200:3891\u20136.","journal-title":"J Immunol"},{"key":"9124_CR10","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1084\/jem.20100363","volume":"207","author":"B Lehnertz","year":"2010","unstructured":"Lehnertz B, Northrop JP, Antignano F, Burrows K, Hadidi S, Mullaly SC, et al. Activating and inhibitory functions for the histone lysine methyltransferase G9a in T helper cell differentiation and function. J Exp Med. 2010;207:915\u201322.","journal-title":"J Exp Med"},{"key":"9124_CR11","doi-asserted-by":"crossref","unstructured":"Jing R, Falchetti M, Han T, Najia M, Hensch LT, Meader E, et al. Maturation and persistence of CAR T cells derived from human pluripotent stem cells via chemical inhibition of G9a\/GLP. Cell Stem Cell. 2025;32:71\u201385.e5.","DOI":"10.1016\/j.stem.2024.10.004"},{"key":"9124_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrg3623","volume":"15","author":"TC Voss","year":"2014","unstructured":"Voss TC, Hager GL. Dynamic regulation of transcriptional states by chromatin and transcription factors. Nat Rev Genet. 2014;15:69\u201381.","journal-title":"Nat Rev Genet"},{"key":"9124_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrg3607","volume":"15","author":"T Chen","year":"2014","unstructured":"Chen T, Dent SY. Chromatin modifiers and remodellers: regulators of cellular differentiation. Nat Rev Genet. 2014;15:93\u2013106.","journal-title":"Nat Rev Genet"},{"key":"9124_CR14","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41588-020-00736-4","volume":"52","author":"MAJ Morgan","year":"2020","unstructured":"Morgan MAJ, Shilatifard A. Reevaluating the roles of histone-modifying enzymes and their associated chromatin modifications in transcriptional regulation. Nat Genet. 2020;52:1271\u201381.","journal-title":"Nat Genet"},{"key":"9124_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41386-025-02179-z","volume":"51","author":"CJ Pe\u00f1a","year":"2026","unstructured":"Pe\u00f1a CJ. Epigenetic regulation of brain development, plasticity, and response to early-life stress. Neuropsychopharmacology. 2026;51:5\u201315.","journal-title":"Neuropsychopharmacology"},{"key":"9124_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-genet-012825-093148","volume":"59","author":"J Xiong","year":"2025","unstructured":"Xiong J, Zhu B. Epigenetic preparation of future gene induction kinetics. Annu Rev Genet. 2025;59:25\u201349.","journal-title":"Annu Rev Genet"},{"key":"9124_CR17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/1535-7163.MCT-21-0743","volume":"21","author":"P Spiliopoulou","year":"2022","unstructured":"Spiliopoulou P, Spear S, Mirza H, Garner I, McGarry L, Grundland-Freile F, et al. Dual G9A\/EZH2 inhibition stimulates antitumor immune response in ovarian high-grade serous carcinoma. Mol Cancer Ther. 2022;21:522\u201334.","journal-title":"Mol Cancer Ther"},{"key":"9124_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173827","volume":"893","author":"S Jan","year":"2021","unstructured":"Jan S, Dar MI, Wani R, Sandey J, Mushtaq I, Lateef S, et al. Targeting EHMT2\/G9a for cancer therapy: progress and perspective. Eur J Pharmacol. 2021;893:173827.","journal-title":"Eur J Pharmacol"},{"key":"9124_CR19","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1158\/1078-0432.CCR-20-3463","volume":"27","author":"GM Kelly","year":"2021","unstructured":"Kelly GM, Al-Ejeh F, McCuaig R, Casciello F, Ahmad Kamal N, Ferguson B, et al. G9a inhibition enhances checkpoint inhibitor blockade response in melanoma. Clin Cancer Res. 2021;27:2624\u201335.","journal-title":"Clin Cancer Res"},{"key":"9124_CR20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1053\/j.gastro.2023.11.294","volume":"166","author":"L Sun","year":"2024","unstructured":"Sun L, Liu R, Wu ZJ, Liu ZY, Wan AH, Yan S, et al. Galectin-7 induction by EHMT2 inhibition enhances immunity in microsatellite stability colorectal cancer. Gastroenterology. 2024;166:466\u201382.","journal-title":"Gastroenterology"},{"key":"9124_CR21","doi-asserted-by":"publisher","first-page":"e001335","DOI":"10.1136\/jitc-2020-001335","volume":"9","author":"JA Seier","year":"2021","unstructured":"Seier JA, Reinhardt J, Saraf K, Ng SS, Layer JP, Corvino D, et al. Druggable epigenetic suppression of interferon-induced chemokine expression linked to MYCN amplification in neuroblastoma. J Immunother Cancer. 2021;9:e001335.","journal-title":"J Immunother Cancer"},{"key":"9124_CR22","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/JLB.1MA0321-155RR","volume":"110","author":"M Yu","year":"2021","unstructured":"Yu M, Su Z, Huang X, Zhou Y, Zhang X, Wang B, et al. Histone methyltransferase Ezh2 negatively regulates NK cell terminal maturation and function. J Leukoc Biol. 2021;110:1033\u201345.","journal-title":"J Leukoc Biol"},{"key":"9124_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.724276","volume":"12","author":"M Yu","year":"2021","unstructured":"Yu M, Su Z, Huang X, Wang X. Single-cell sequencing reveals the novel role of Ezh2 in NK cell maturation and function. Front Immunol. 2021;12:724276.","journal-title":"Front Immunol"},{"key":"9124_CR24","doi-asserted-by":"publisher","first-page":"15988","DOI":"10.1073\/pnas.1521740112","volume":"112","author":"J Yin","year":"2015","unstructured":"Yin J, Leavenworth JW, Li Y, Luo Q, Xie H, Liu X, et al. Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity. Proc Natl Acad Sci USA. 2015;112:15988\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9124_CR25","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884\u2013i890.","journal-title":"Bioinformatics"},{"key":"9124_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"9124_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31:166\u20139.","journal-title":"Bioinformatics"},{"key":"9124_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"9124_CR29","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.4049\/jimmunol.1001682","volume":"185","author":"MA Smith","year":"2010","unstructured":"Smith MA, Maurin M, Cho HI, Becknell B, Freud AG, Yu J, et al. PRDM1\/Blimp-1 controls effector cytokine production in human NK cells. J Immunol. 2010;185:6058\u201367.","journal-title":"J Immunol"},{"key":"9124_CR30","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"9124_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"9124_CR32","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841\u20132.","journal-title":"Bioinformatics"},{"key":"9124_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13072-019-0287-4","volume":"12","author":"MP Meers","year":"2019","unstructured":"Meers MP, Tenenbaum D, Henikoff S. Peak calling by sparse enrichment analysis for CUT&RUN chromatin profiling. Epigenet Chromatin. 2019;12:42.","journal-title":"Epigenet Chromatin"},{"key":"9124_CR34","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38:576\u201389.","journal-title":"Mol Cell"},{"key":"9124_CR35","doi-asserted-by":"publisher","first-page":"W187","DOI":"10.1093\/nar\/gku365","volume":"42","author":"F Ram\u00edrez","year":"2014","unstructured":"Ram\u00edrez F, D\u00fcndar F, Diehl S, Gr\u00fcning BA, Manke T. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 2014;42:W187\u2013191.","journal-title":"Nucleic Acids Res"},{"key":"9124_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24\u201326.","journal-title":"Nat Biotechnol"},{"key":"9124_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-3-r16","volume":"13","author":"Z Shao","year":"2012","unstructured":"Shao Z, Zhang Y, Yuan GC, Orkin SH, Waxman DJ. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets. Genome Biol. 2012;13:R16.","journal-title":"Genome Biol"},{"key":"9124_CR38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16:284\u20137.","journal-title":"Omics"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09124-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09124-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09124-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:07:46Z","timestamp":1789996066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09124-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9124"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09124-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"820"}}